SEARCH

SEARCH BY CITATION

References

  • 1
    Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656660.
  • 2
    van der Lely, A. J., Tschop, M., Heiman, M. L., and Ghigo, E. (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25, 426457.
  • 3
    Broglio, F., Arvat, E., Benso, A., Gottero, C., Muccioli, G., et al. (2001) Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J. Clin. Endocrinol. Metab. 86, 50835086.
  • 4
    Dezaki, K. (2013) Ghrelin function in insulin release and glucose metabolism. Endocr. Dev. 25, 135143.
  • 5
    Gutierrez, J. A., Solenberg, P. J., Perkins, D. R., Willency, J. A., Knierman, M. D., et al. (2008) Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. U.S.A. 105, 63206325.
  • 6
    Yang, J., Brown, M. S., Liang, G., Grishin, N. V., and Goldstein, J. L. (2008) Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387396.
  • 7
    Sun, Y., Wang, P., Zheng, H., and Smith, R. G. (2004) Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. U.S.A. 101, 46794684.
  • 8
    Zhang, J. V., Ren, P. G., Avsian-Kretchmer, O., Luo, C. W., Rauch, R., et al. (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310, 996999.
  • 9
    Delhanty, P. J., Neggers, S. J., and van der Lely, A. J. (2013) Des-acyl ghrelin: a metabolically active peptide. Endocr. Dev. 25, 112121.
  • 10
    Granata, R., Gallo, D., Luque, R. M., Baragli, A., Scarlatti, F., et al. (2012) Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J 26, 33933411.
  • 11
    Granata, R., Baragli, A., Settanni, F., Scarlatti, F., and Ghigo, E. (2010) Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J. Mol. Endocrinol. 45, 107118.
  • 12
    Granata, R., Settanni, F., Julien, M., Nano, R., Togliatto, G., et al. (2012) Des-acyl ghrelin fragments and analogues promote survival of pancreatic beta-cells and human pancreatic islets and prevent diabetes in streptozotocin-treated rats. J. Med. Chem. 55, 25852596.
  • 13
    Granata, R. and Ghigo, E. (2013) Products of the ghrelin gene, the pancreatic beta-cell and the adipocyte. Endocr. Dev. 25, 144156.
  • 14
    Muccioli, G., Baragli, A., Granata, R., Papotti, M., and Ghigo, E. (2007) Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology 86, 147164.
  • 15
    Davenport, A. P., Alexander, S. P., Sharman, J. L., Pawson, A. J., Benson, H. E., et al. (2013) International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol. Rev. 65, 967986.
  • 16
    Granata, R., Settanni, F., Gallo, D., Trovato, L., Biancone, L., et al. (2008) Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 57, 967979.
  • 17
    Baldanzi, G., Filigheddu, N., Cutrupi, S., Catapano, F., Bonissoni, S., et al. (2002) Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell. Biol. 159, 10291037.
  • 18
    Granata, R., Settanni, F., Biancone, L., Trovato, L., Nano, R., et al. (2007) Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 148, 512529.
  • 19
    Hassouna, R., Zizzari, P., Viltart, O., Yang, S. K., Gardette, R., et al. (2012) A natural variant of obestatin, Q90L, inhibits ghrelin's action on food intake and GH secretion and targets NPY and GHRH neurons in mice. PLoS One 7, e51135.
  • 20
    Zizzari, P., Longchamps, R., Epelbaum, J., and Bluet-Pajot, M. T. (2007) Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 148, 16481653.
  • 21
    Bresciani, E., Rapetti, D., Dona, F., Bulgarelli, I., Tamiazzo, L., et al. (2006) Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J. Endocrinol. Invest. 29, RC1618.
  • 22
    Green, B. D., Irwin, N., and Flatt, P. R. (2007) Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 28, 981987.
  • 23
    Nagaraj, S., Peddha, M. S., and Manjappara, U. V. (2008) Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat. Biochem. Biophys. Res. Commun. 366, 731737.
  • 24
    Zhang, J. V., Jahr, H., Luo, C. W., Klein, C., Van Kolen, K., et al. (2008) Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol. Endocrinol. 22, 14641475.
  • 25
    Ren, A. J., Guo, Z. F., Wang, Y. K., Lin, L., Zheng, X., et al. (2009) Obestatin, obesity and diabetes. Peptides 30, 439444.
  • 26
    Chartrel, N., Alvear-Perez, R., Leprince, J., Iturrioz, X., Reaux-Le Goazigo, A., et al. (2007) Comment on “Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake”. Science 315, 766; author reply 766.
  • 27
    Nogueiras, R., Pfluger, P., Tovar, S., Arnold, M., Mitchell, S., et al. (2007) Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148, 2126.
  • 28
    Samson, W. K., White, M. M., Price, C., and Ferguson, A. V. (2007) Obestatin acts in brain to inhibit thirst. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R637643.
  • 29
    Carlini, V. P., Schioth, H. B., and Debarioglio, S. R. (2007) Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem. Biophys. Res. Commun. 352, 907912.
  • 30
    Szentirmai, E. and Krueger, J. M. (2006) Obestatin alters sleep in rats. Neurosci. Lett. 404, 222226.
  • 31
    Granata, R., Volante, M., Settanni, F., Gauna, C., Ghe, C., et al. (2010) Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats. J. Mol. Endocrinol. 45, 917.
  • 32
    Favaro, E., Granata, R., Miceli, I., Baragli, A., Settanni, F., et al. (2012) The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways. Diabetologia 55, 10581070.
  • 33
    Alloatti, G., Arnoletti, E., Bassino, E., Penna, C., Perrelli, M. G., et al. (2010) Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 299, H470481.
  • 34
    Ersahin, M., Ozsavci, D., Sener, A., Ozakpinar, O. B., Toklu, H. Z., et al. (2013) Obestatin alleviates subarachnoid haemorrhage-induced oxidative injury in rats via its anti-apoptotic and antioxidant effects. Brain Inj. 27, 11811189.
  • 35
    Baragli, L., Grande, C., Gesmundo, I., Settanni, F., Taliano, M., et al. (2013) Correction: obestatin enhances in vitro generation of pancreatic islets through regulation of developmental pathways. PLoS ONE 8.
  • 36
    Baragli, L., Grande, C., Gesmundo, I., Settanni, F., Taliano, M., et al. (2013) Obestatin enhances in vitro generation of pancreatic islets through regulation of developmental pathways. PLoS One 8, e64374.
  • 37
    Gurriaran-Rodriguez, U., Al-Massadi, O., Roca-Rivada, A., Crujeiras, A. B., Gallego, R., et al. (2011) Obestatin as a regulator of adipocyte metabolism and adipogenesis. J. Cell. Mol. Med. 15, 19271940.
  • 38
    Miegueu, P., St. Pierre, D., Broglio, F., and Cianflone, K. (2011) Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J. Cell. Biochem. 112, 704714.
  • 39
    Pruszynska-Oszmalek, E., Szczepankiewicz, D., Hertig, I., Skrzypski, M., Sassek, M., et al. (2013) Obestatin inhibits lipogenesis and glucose uptake in isolated primary rat adipocytes. J. Biol. Regul. Homeost. Agents 27, 2333.
  • 40
    Ren, G., He, Z., Cong, P., Chen, H., Guo, Y., et al. (2013) Peripheral administration of TAT-obestatin can influence the expression of liporegulatory genes but fails to affect food intake in mice. Peptides 42C, 814.
  • 41
    Aragno, M., Mastrocola, R., Ghe, C., Arnoletti, E., Bassino, E., et al. (2012) Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. Cardiovasc. Diabetol. 11, 129.
  • 42
    Granata, R., Isgaard, J., Alloatti, G., and Ghigo, E. (2011) Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone. Exp. Biol. Med. (Maywood) 236, 505514.
  • 43
    Ceranowicz, P., Warzecha, Z., Dembinski, A., Cieszkowski, J., Dembinski, M., et al. (2009) Pretreatment with obestatin inhibits the development of cerulein-induced pancreatitis. J. Physiol. Pharmacol. 60, 95101.
  • 44
    Lauwers, E., Landuyt, B., Arckens, L., Schoofs, L., and Luyten, W. (2006) Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem. Biophys. Res. Commun. 351, 2125.
  • 45
    Holst, B., Egerod, K. L., Schild, E., Vickers, S. P., Cheetham, S., et al. (2007) GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148, 1320.
  • 46
    Zhang, J. V., Li, L., Huang, Q., and Ren, P. G. (2013) Obestatin receptor in energy homeostasis and obesity pathogenesis. Prog. Mol. Biol. Transl. Sci. 114, 89107.
  • 47
    Drucker, D. J. (2006) The biology of incretin hormones. Cell. Metab. 3, 153165.
  • 48
    Iglesias, M. J., Salgado, A., Pineiro, R., Rodino, B. K., Otero, M. F., et al. (2007) Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism. J. Endocrinol. Invest. 30, 470476.
  • 49
    Nakahara, T., Harada, T., Yasuhara, D., Shimada, N., Amitani, H., et al. (2008) Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol. Psychiatry 64, 252255.
  • 50
    Uehara, M., Yasuhara, D., Nakahara, T., Harada, T., Koyama, K. I., et al. (2011) Increase in energy intake leads to a decrease in obestatin in restricting-type of anorexia nervosa. Exp. Clin. Endocrinol. Diabetes 119, 536539.
  • 51
    Monteleone, P., Serritella, C., Martiadis, V., Scognamiglio, P., and Maj, M. (2008) Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J. Clin. Endocrinol. Metab. 93, 44184421.
  • 52
    Germain, N., Galusca, B., Grouselle, D., Frere, D., Billard, S., et al. (2010) Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. J. Clin. Endocrinol. Metab. 95, 30573062.
  • 53
    Sedlackova, D., Kopeckova, J., Papezova, H., Vybiral, S., Kvasnickova, H., et al. (2011) Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast. Physiol. Res. 60, 165173.
  • 54
    Walia, P., Asadi, A., Kieffer, T. J., Johnson, J. D., and Chanoine, J. P. (2009) Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach. Pediatr. Res. 65, 3944.
  • 55
    Donath, M. Y. and Halban, P. A. (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47, 581589.
  • 56
    Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., et al. (2003) cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev. 17, 15751580.
  • 57
    Doyle, M. E. and Egan, J. M. (2007) Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol. Ther. 113, 546593.
  • 58
    Terauchi, Y., Takamoto, I., Kubota, N., Matsui, J., Suzuki, R., et al. (2007) Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J. Clin. Invest. 117, 246257.
  • 59
    Wierup, N., Svensson, H., Mulder, H., and Sundler, F. (2002) The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul. Pept. 107, 6369.
  • 60
    Qader, S. S., Hakanson, R., Rehfeld, J. F., Lundquist, I., and Salehi, A. (2008) Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul. Pept. 146, 230237.
  • 61
    Ren, A. J., Guo, Z. F., Wang, Y. K., Wang, L. G., Wang, W. Z., et al. (2008) Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem. Biophys. Res. Commun. 369, 969972.
  • 62
    Egido, E. M., Hernandez, R., Marco, J., and Silvestre, R. A. (2009) Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul. Pept. 152, 6166.
  • 63
    Guilherme, A., Virbasius, J. V., Puri, V., and Czech, M. P. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell. Biol. 9, 367377.
  • 64
    Hotamisligil, G. S. (2006) Inflammation and metabolic disorders. Nature 444, 860867.
  • 65
    Challa, T. D., Beaton, N., Arnold, M., Rudofsky, G., Langhans, W., et al. (2012) Regulation of adipocyte formation by GLP-1/GLP-1R signalling. J Biol Chem 287, 64216430.
  • 66
    Choi, K., Roh, S. G., Hong, Y. H., Shrestha, Y. B., Hishikawa, D., et al. (2003) The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 144, 754759.
  • 67
    Kim, M. S., Yoon, C. Y., Jang, P. G., Park, Y. J., Shin, C. S., et al. (2004) The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol. Endocrinol. 18, 22912301.
  • 68
    Baragli, A., Ghe, C., Arnoletti, E., Granata, R., Ghigo, E., et al. (2011) Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase gamma and phosphodiesterase 3B. Biochim. Biophys. Acta 1811, 386396.
  • 69
    Bourron, O., Daval, M., Hainault, I., Hajduch, E., Servant, J. M., et al. (2010) Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia 53, 768778.
  • 70
    Grala, T. M., Kay, J. K., Walker, C. G., Sheahan, A. J., Littlejohn, M. D., et al. (2010) Expression analysis of key somatotropic axis and liporegulatory genes in ghrelin- and obestatin-infused dairy cows. Domest. Anim. Endocrinol. 39, 7683.
  • 71
    Yoshizaki, T., Milne, J. C., Imamura, T., Schenk, S., Sonoda, N., et al. (2009) SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol. Cell. Biol. 29, 13631374.
  • 72
    Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 17841792.
  • 73
    Siegrist-Kaiser, C. A., Pauli, V., Juge-Aubry, C. E., Boss, O., Pernin, A., et al. (1997) Direct effects of leptin on brown and white adipose tissue. J. Clin. Invest. 100, 28582864.
  • 74
    Kim, J. Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117, 26212637.